The scientistsnoted that with one doseofcancer-resistant white blood cells, normalanimalsacquiredcancerimmunity that typicallylasted for the rest of their lives.
HSE, however, were resistant to plenty of disease-causing agents other than the H. simplex virus, suggesting that innate immunity could be specific, too.